http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Oct 2026 06:11:07 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Starts+Sight+Sciences+Inc.+%28SGHT%29+at+Buy/27188962.html <p>H.C. Wainwright initiates coverage on Sight Sciences Inc. (NASDAQ: SGHT) with a Buy rating and a price target of $14.00.</p><p>For an analyst ratings summary and ratings history on Sight Sciences Inc. <a href="http://www.streetinsider.com/rating_history.php?q=SGHT">click here</a>. For more ratings news on Sight Sciences Inc. <a href="http://www.streetinsider.com/stock_lookup_news.php?q=SGHT&amp;type=analyst">click here</a>.</p><p>Shares of Sight Sciences Inc. closed at $8.25 yesterday.</p> http://www.streetinsider.com/New+Coverage/H.C.+Wainwright+Starts+Sight+Sciences+Inc.+%28SGHT%29+at+Buy/27188962.html Thu, 15 Oct 2026 06:11:07 -0400 SGHT http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html <p>While for some time in August there was optimism about the U.S. MedTech universe, post September, the whole sector has gone back to taking a beating, notes Citi in its preview into Q3 earnings of the sector. Firm analysts say they have low expectations from the earnings print, but will be looking for pockets of growth and recovery into 2027.</p><p>Procedure volumes, hospital capex, the macro environment, and idiosyncratic overhangs have all been blamed for weighing the sector down, but these all seem like rationalisations, the firm noted. Previously, investors were focusing on an island of medtech stocks with at least http://www.streetinsider.com/Hot+List+Pro/U.S.+MedTech+stocks%3A+Q3+earnings+preview/27172882.html Sun, 11 Oct 2026 15:00:00 -0400 ABT BSX DXCM EW SGHT SYK ZBH http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Taylor+Brenton/27149465.html si-local-file:///var/storage/secattach/20261005/27149465.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Taylor+Brenton/27149465.html Mon, 05 Oct 2026 16:44:00 -0400 SGHT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Bauerlein+Alison/27149455.html si-local-file:///var/storage/secattach/20261005/27149455.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Bauerlein+Alison/27149455.html Mon, 05 Oct 2026 16:43:00 -0400 SGHT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Rodberg+James/27149436.html si-local-file:///var/storage/secattach/20261005/27149436.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+02++Filed+by%3A+Rodberg+James/27149436.html Mon, 05 Oct 2026 16:42:00 -0400 SGHT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+01++Filed+by%3A+Badawi+David/27149399.html si-local-file:///var/storage/secattach/20261005/27149399.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+01++Filed+by%3A+Badawi+David/27149399.html Mon, 05 Oct 2026 16:41:00 -0400 SGHT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+01++Filed+by%3A+Badawi+Paul/27149393.html si-local-file:///var/storage/secattach/20261005/27149393.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sight+Sciences%2C+Inc.++++++For%3A+Oct+01++Filed+by%3A+Badawi+Paul/27149393.html Mon, 05 Oct 2026 16:40:00 -0400 SGHT http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html <p>Citi Adjusts Catalyst Watch List.</p><ul><li>Sight Sciences (NASDAQ: SGHT) adds to 90-Day upside catalyst watch list.</li><li>Zimmer Biomet Holdings (NYSE: ZBH) adds to 90-Day upside catalyst watch list.</li><li>Edwards Lifesciences (NYSE: EW) adds to 90-Day upside catalyst watch list.</li><li>Boston Scientific (NYSE: BSX) adds to 90-Day upside catalyst watch list.</li></ul> http://www.streetinsider.com/Trader+Talk/Citi+Adjusts+Catalyst+Watch+List/27145352.html Mon, 05 Oct 2026 06:57:43 -0400 BSX EW SGHT ZBH http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/27142939.html si-local-file:///var/storage/secattach/20261002/27142939.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++Sight+Sciences%2C+Inc.+++++++++++++++++++Filed+by%3A+Bauerlein+Alison/27142939.html Fri, 02 Oct 2026 16:35:00 -0400 SGHT